Russell B L, Martin S M
Medical College of Georgia, Augusta 30912, USA.
Clin Lab Sci. 1997 Nov-Dec;10(6):321-4.
This study compared 2 different methodologies: hemoglobin by the HemoCue instrument and hematocrit by the microhematocrit method, to determine if there were any significant difference in the values that could affect donor rejection rates. Literature from the 1960s to 1990s reveals a variety of methods for hemoglobin and hematocrit determinations as well as discussions on fingerstick versus earlobe capillary samples. The HemoCue hemoglobin analyzer is a relatively new technology that tests capillary specimens. The copper sulfate method, although the method of choice for measuring prospective donor hemoglobin levels for many years, was not a part of the study. The microhematocrit method has historically been used as the method for measuring hematocrit alone or as a secondary procedure when donors failed the copper sulfate screening test.
使用HemoCue仪器测定血红蛋白以及采用微量血细胞比容法测定血细胞比容,以确定这些数值是否存在可能影响供体排斥率的显著差异。20世纪60年代至90年代的文献揭示了多种血红蛋白和血细胞比容的测定方法,以及关于手指采血与耳垂毛细血管采血样本的讨论。HemoCue血红蛋白分析仪是一种检测毛细血管标本的相对新技术。硫酸铜法虽然多年来一直是测量潜在供体血红蛋白水平的首选方法,但并非本研究的一部分。从历史上看,微量血细胞比容法一直被用作单独测量血细胞比容的方法,或者当供体硫酸铜筛查试验不合格时作为辅助程序。